FDA Approves "Promising" Treatment for Multiple Sclerosis

The FDA has approved the drug, Ocrevus, for treatment of multiple sclerosis.  While the drug is promising, it does have some potential side effects.  Dr. Rana Zabad told us more about Ocrevus and the promise that it may hold for M.S. patients.  Here's is a link to a story about Ocrevus.

 
Gary Sadlemyer and KFAB's Morning News

Gary Sadlemyer and KFAB's Morning News

Want to know more about KFAB Morning News?

title

Content Goes Here